drugset / Trial / NCT01871077

Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.

NCT01871077

Phase 1 Completed 30 enrolled Laboratorios Sophia S.A de C.V.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate safety and tolerability of the ophthalmic solution PRO-156 over the ocular surface of ophthalmologically healthy volunteers

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified

Indications

No indication recorded.